Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions

Fabry disease (FD) is a lysosomal storage disorder (LSD) characterized by the deficiency of α-galactosidase A (α-GalA) and the consequent accumulation of toxic metabolites such as globotriaosylceramide (Gb3) and globotriaosylsphingosine (lysoGb3). Early diagnosis and appropriate timely treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kok, Ken, Zwiers, Kimberley C., Boot, Rolf G., Overkleeft, Hermen S., Aerts, Johannes M. F. G., Artola, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918333/
https://www.ncbi.nlm.nih.gov/pubmed/33673160
http://dx.doi.org/10.3390/biom11020271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918333/
https://www.ncbi.nlm.nih.gov/pubmed/33673160
http://dx.doi.org/10.3390/biom11020271

Ejemplares similares